Adriaan Voors

Cardiologist

Adriaan Voors is Professor of Cardiology and specializes in heart failure. Since July 2003, Professor Voors works as a Cardiologist in the University Medical Centre Groningen, The Netherlands. In 2007, he became Established Clinical Investigator of the Netherlands Heart Foundation, and in May 2010, he became Professor of Cardiology at the University Medical Center Groningen.

Current activities

Professor Voors is chairing a research group of students, MD-PhD-fellows and post-docs mainly on using –omics data to increase our knowledge on pathophysiology leading to personalized therapies in heart failure. He is an editorial board member of the European Journal of Heart Failure, Clinical Research in Cardiology Cardiovascular Drugs and Therapy, the Journal of Cardiovascular Medicine, and Heart Failure Reviews. He is/was involved as principal investigator/executive/steering committee member of 44 clinical trials on novel therapies in acute and chronic heart failure. Prof. Voors was a member of the 2012 ESC Heart Failure Guidelines Committee, and is the co-chair of the 2016 ESC Heart Failure Guidelines. He has authored more than 500 peer-reviewed papers and several books and chapters and his Hirsch-index is 81.

My projects

BIOSTAT-CHF

Facilitate personalized therapies in patients with heart failure

PROMINENT

Personalised Medicine in Chronic Disease Management

My publications

Sex-specific associations of obesity and N-Terminal Pro-B-Type Natriuretic Peptide levels in the general population

Navin Suthahar, Wouter C Meijers, Jennifer E Ho, Ron T Gansevoort, Adriaan A Voors, Peter van der Meer, Stephan J L Bakker, Stephane Heymans, Vanessa van Empel, Blanche Schroen, Pim van der Harst, Dirk J van Veldhuisen, and Rudolf A de Boer. Eur J Heart Fail. 2018.

view on PubMed

A single dose of erythropoietin in ST-elevation myocardial infarction.

Voors AA, Belonje AM, Zijlstra F, Hillege HL, Anker SD, Slart RH, Tio RA, van 't Hof A, Jukema JW, Peels HO, Henriques JP, Ten Berg JM, Vos J, van Gilst WH, van Veldhuisen DJ; HEBE III Investigators. Eur Heart J. 2010

view on publisher site

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.

Tromp J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Lang CC, Ng LL, Zannad F, Zwinderman AH, Hillege HL, van der Meer P, Voors AA. J Am Coll Cardiol. 2018

view on publisher site

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Ponikowski P, Voors AA, ESC Scientific Document Group. Eur Heart J. 2016

view on publisher site

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).

Damman K, Beusekamp JC, Boorsma EM, Swart HP, Smilde TDJ, Elvan A, van Eck JWM, Heerspink HJL, Voors AA. Eur J Heart Fail. 2020

view on publisher site